Pluri Inc. (PluriStem Life Systems, Inc.) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on April 3, 2006, by PluriStem Life Systems, Inc., a Nevada corporation headquartered in Haifa, Israel. The filing discloses a significant financing transaction and a change in corporate leadership effective April 3, 2006.
Key Financial Metrics and Transaction Details
- Debt Financing: Issued 7% Senior Secured Convertible Debentures Series 06-01 with gross proceeds of $3,000,000.
- Maturity: Debentures mature on April 3, 2008.
- Interest: 7% per annum, payable semi-annually (June 30 and December 31) or upon conversion/maturity. Interest may be paid in cash or shares at the company's option.
- Warrants Issued: 47,393,364 common share purchase warrants issued to investors (3-year term, exercise price $0.075).
- Finder's Fees: Paid 10% of proceeds in cash plus 9,478,672 warrants (split between exercise prices of $0.075 and $0.077).
- Collateral: The company granted a security interest in substantially all assets, including intellectual property, to secure the debentures.
- Liquidity and Cash Flow: The filing does not provide specific cash flow statements, balance sheet totals, or revenue figures for the period.
Material Changes and Terms
- Conversion Terms: Debentures are convertible at the lower of 75% of the 20-day volume-weighted average trading price prior to conversion notice or the lowest price of any subsequent financing transaction.
- Prepayment: The company may prepay the debentures (subject to registration effectiveness) by paying 120% of the principal plus accrued interest.
- Registration Rights: The company agreed to file a registration statement within 30 days of closing. Failure to file or have it declared effective within 120 days may trigger substantial liquidated damages.
- Lock-up Agreements: Directors and officers agreed not to sell shares for 6 months after the registration statement becomes effective, with volume limitations thereafter.
- Leadership Change: Doron Shorrer resigned as Chairman of the Board; Zami Aberman was appointed Acting Chairman.
Outlook, Risks, and Contingencies
- Registration Risk: Significant financial liability exists if the registration statement is not filed timely or declared effective within 120 days, or if suspended beyond agreed periods.
- Conversion Limitations: Holders cannot convert or exercise warrants if the resulting share ownership would exceed 4.99% of the company's outstanding shares.
- Future Financing Restrictions: Until less than 25% of the principal remains unconverted, the company cannot enter into new transactions with variable conversion/exercise prices without 51% debenture holder consent. Additionally, no new securities sales are permitted until the registration statement is effective.
- Default Provisions: Holders may require redemption of debentures upon specified events of default.
Investor Verification Checklist
- Verify the status of the registration statement filing and its effectiveness date to assess liquidated damages risk.
- Confirm the current cash position and ability to service the 7% interest payments or convert to equity.
- Review the Security Interest Agreement to understand the scope of assets pledged against the $3 million debt.
- Monitor the 4.99% beneficial ownership limitation to understand potential dilution caps for investors.
- Check for any subsequent financing transactions that could trigger price adjustments on the conversion rate.